Lattice Biologics Ltd
OTC:LBLTF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Chiba Kogyo Bank Ltd
TSE:8337
|
JP |
Lattice Biologics Ltd
Inventory
Lattice Biologics Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Lattice Biologics Ltd
XTSX:LBL
|
Inventory
$518.5k
|
CAGR 3-Years
-35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Inventory
$5B
|
CAGR 3-Years
11%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Inventory
$1.8B
|
CAGR 3-Years
6%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-1%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Inventory
$6.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
10%
|
CAGR 10-Years
10%
|
|
|
Exact Sciences Corp
NASDAQ:EXAS
|
Inventory
$166.2m
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
38%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Inventory
$1.7B
|
CAGR 3-Years
54%
|
CAGR 5-Years
43%
|
CAGR 10-Years
40%
|
|
Lattice Biologics Ltd
Glance View
Lattice Biologics, Ltd. is a biotech company. The company is headquartered in Scottsdale, Arizona. The firm is a precision medicine company in the field of cellular therapies and tissue engineering, with a focus on bone, skin and cartilage regeneration. The company produces and distributes multiple allograft tissue products used by surgeons as bone, skin and cartilage tissue void fillers. Its products include Acellular Demineralized Bone Scaffold, Demineralized Bone Matrix putty (DBM Putty), Acellular dermal matrix (ADM) dermal scaffold and Other Products. Its products are used in a range of applications, including enhancing fusion in spine surgery; enhancing breast reconstruction post mastectomy; sports medicine indications, including anterior cruciate ligament repair and promotion of bone growth in foot; promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries.
See Also
What is Lattice Biologics Ltd's Inventory?
Inventory
518.5k
USD
Based on the financial report for Sep 30, 2020, Lattice Biologics Ltd's Inventory amounts to 518.5k USD.
What is Lattice Biologics Ltd's Inventory growth rate?
Inventory CAGR 3Y
-35%
Over the last year, the Inventory growth was -26%. The average annual Inventory growth rates for Lattice Biologics Ltd have been -35% over the past three years .